{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:50:15Z","timestamp":1761918615883},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.cancergencyto.2003.12.014","type":"journal-article","created":{"date-parts":[[2004,8,19]],"date-time":"2004-08-19T13:10:26Z","timestamp":1092921026000},"page":"39-47","source":"Crossref","is-referenced-by-count":21,"title":["Cytogenetic profile of myelodysplastic syndromes with complex karyotypes: an analysis using spectral karyotyping"],"prefix":"10.1016","volume":"153","author":[{"given":"Angel","family":"Mart\u0131\u0301nez-Ram\u0131\u0301rez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Urioste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Luis Vizmanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Jos\u00e9 Calasanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Cruz Cigudosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Ben\u0131\u0301tez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2003.12.014_BIB1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/gcc.10027","article-title":"Spectral karyotyping in patients with acute myeloid leukemia and a complex karyotype shows hidden aberrations, including recurrent overrepresentation of 21q, 11q, and 22q","volume":"34","author":"Mr\u00f3zek","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2003.12.014_BIB2","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/gcc.2870090307","article-title":"t(12;21): a new recurrent translocation in acute lymphoblastic leukemia","volume":"9","author":"Romana","year":"1994","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2003.12.014_BIB3","first-page":"1245","article-title":"Fluorescence in situ hybridization study of TEL\/AML1 fusion and other abnormalities involving TEL and AML1 genes. Correlation with cytogenetic findings and prognostic value in children with acute lymphocytic leukemia","volume":"86","author":"Martinez-Ramirez","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergencyto.2003.12.014_BIB4","first-page":"127","article-title":"Cytogenetics of myelodysplastic syndromes","volume":"33","author":"Fenaux","year":"1996","journal-title":"Semin Hematol"},{"key":"10.1016\/j.cancergencyto.2003.12.014_BIB5","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2003.12.014_BIB6","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0037-1963(00)90014-3","article-title":"Spectral karyotyping and multicolor fluorescence in situ hybridization reveal new tumor-specific chromosomal aberrations","volume":"37","author":"Schrock","year":"2000","journal-title":"Semin Hematol"},{"key":"10.1016\/j.cancergencyto.2003.12.014_BIB7","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng0497-406","article-title":"Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping","volume":"15","author":"Veldman","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergencyto.2003.12.014_BIB8","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/(SICI)1098-2264(199912)26:4<336::AID-GCC8>3.0.CO;2-H","article-title":"Combined spectral karyotyping and DAPI banding analysis of chromosome abnormalities in myelodysplastic syndrome","volume":"26","author":"Kakazu","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2003.12.014_BIB9","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/sj.leu.2401775","article-title":"Comparison of spectral karyotyping and conventional cytogenetics in 39 patients with acute myeloid leukemia and myelodysplastic syndrome","volume":"14","author":"Mohr","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2003.12.014_BIB10","first-page":"1158","article-title":"Molecular cytogenetic characterization of acute myeloid leukemia and myelodysplastic syndromes with multiple chromosome rearrangements","volume":"86","author":"Lindvall","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergencyto.2003.12.014_BIB11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/gcc.1212","article-title":"Identification of cytogenetic subclasses and recurring chromosomal aberrations in AML and MDS with complex karyotypes using M-FISH","volume":"33","author":"Van Limbergen","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2003.12.014_BIB12","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2141.1984.tb03982.x","article-title":"Myelodysplastic syndromes: is another classification necessary?","volume":"56","author":"Bennett","year":"1984","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2003.12.014_BIB13","series-title":"ISCN guidelines for cancer cytogenetics","year":"1995"},{"key":"10.1016\/j.cancergencyto.2003.12.014_BIB14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1096-8652(199705)55:1<1::AID-AJH1>3.0.CO;2-Y","article-title":"Correlation between mutations in p53 gene and protein expression in human lymphomas","volume":"55","author":"Martinez-Delgado","year":"1997","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cancergencyto.2003.12.014_BIB15","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/sj.onc.1206236","article-title":"Methylation of CpG dinucleotides and\/or CCWGG motifs at the promoter of TP53 correlates with decreased gene expression in a subset of acute lymphoblastic leukemia patients","volume":"22","author":"Agirre","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergencyto.2003.12.014_BIB16","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1046\/j.1365-2141.2001.02511.x","article-title":"Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients","volume":"112","author":"Schoch","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2003.12.014_BIB17","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood.V92.7.2322","article-title":"The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties","volume":"92","author":"Grimwade","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2003.12.014_BIB18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/gcc.10088","article-title":"Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH","volume":"35","author":"Schoch","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2003.12.014_BIB19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0165-4608(85)90010-X","article-title":"Karyotypic evolution in patients with myelodysplastic syndromes","volume":"16","author":"Benitez","year":"1985","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2003.12.014_BIB20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0165-4608(90)90102-G","article-title":"Translocations (5;17) and (7;17) in patients with de novo or therapy- related myelodysplastic syndromes or acute nonlymphocytic leukemia. A possible association with acquired pseudo-Pelger-Huet anomaly and small vacuolated granulocytes","volume":"46","author":"Lai","year":"1990","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2003.12.014_BIB21","first-page":"370","article-title":"Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoiesis and a high incidence of P53 mutations","volume":"9","author":"Lai","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2003.12.014_BIB22","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1182\/blood.V91.3.1008","article-title":"17p deletion in acute myeloid leukemia and myelodysplastic syndrome. Analysis of breakpoints and deleted segments by fluorescence in situ","volume":"91","author":"Soenen","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2003.12.014_BIB23","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1182\/blood.V91.2.616","article-title":"Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion","volume":"91","author":"Sterkers","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2003.12.014_BIB24","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0165-4608(00)00431-3","article-title":"Amplification of ERBB2, RARA, and TOP2A genes in a myelodysplastic syndrome transforming to acute myeloid leukemia","volume":"127","author":"Martin-Subero","year":"2001","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2003.12.014_BIB25","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/sj.leu.2401919","article-title":"MLL amplification in acute leukaemia: a UK Cancer Cytogenetics Group (UKCCG) study","volume":"14","author":"Cuthbert","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2003.12.014_BIB26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/1098-2264(2000)9999:9999<::AID-GCC1003>3.3.CO;2-L","article-title":"MLL amplification in myeloid leukemias: a study of 14 cases with multiple copies of 11q23","volume":"29","author":"Michaux","year":"2000","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2003.12.014_BIB27","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/(SICI)1098-2264(200004)27:4<380::AID-GCC7>3.0.CO;2-#","article-title":"Amplification of the MLL gene on double minutes, a homogeneously staining region, and ring chromosomes in five patients with acute myeloid leukemia or myelodysplastic syndrome","volume":"27","author":"Streubel","year":"2000","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2003.12.014_BIB28","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1046\/j.1365-2141.2001.02723.x","article-title":"Spectral karyotyping and fluorescence in situ hybridization detect novel chromosomal aberrations a recurring involvement of chromosome 21 and amplification of the MYC oncogene in acute myeloid leukaemia M2","volume":"113","author":"Hilgenfeld","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2003.12.014_BIB29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.leu.2402766","article-title":"New mechanisms of AML1 gene alteration in hematological malignancies","volume":"17","author":"Roumier","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2003.12.014_BIB30","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1182\/blood.V95.6.2138","article-title":"Deletions of chromosome 5q13.3 and 17p loci cooperate in myeloid neoplasms","volume":"95","author":"Castro","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2003.12.014_BIB31","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1200\/JCO.2001.19.5.1405","article-title":"Mutations with loss of heterozygosity of p53 are common in therapy- related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q a complex karyotype and a poor prognosis","volume":"19","author":"Christiansen","year":"2001","journal-title":"J Clin Oncol"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460803005405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460803005405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T00:51:31Z","timestamp":1585875091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460803005405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0165460803005405"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2003.12.014","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}